Patient Advocacy: Under the Influence of Big Pharma?

The Agenda with Steve Paikin

Beginning in the early 1990s, as state-funding dried out, patient advocacy groups - collectives meant to express the needs of those suffering from serious diseases - were co-opted by pharmaceutical companies offering money in exchange for influence. So says author Sharon Batt, who details big pharma's supposed interference in her new book, "Health Advocacy Inc." Steve Paikin talks to her about the extent of this encroachment, and whether it has compromised Canada's patient advocacy organizations.
Patient Groups and Big Pharma; Multi-Ethnic Donors Needed
Mar 14, 2018
Thinking of your experience with, how likely are you to recommend to a friend or colleague?
Not at all Likely
Extremely Likely
OPINION: With the election more than a year away, it’s not realistic to expect them to have all the details. But there are some big questions they’ll need to answer.

The latest coronavirus updates from across the province.

OPINION: In summer 2019, the premier, with his office in chaos, went dark. Two years and a pandemic later, he’s making a repeat performance. speaks with McMaster University’s Menaka Pai about symptoms, proper care, and the risks associated with getting a second dose.
The latest coronavirus updates from across the province.
Rouge National Urban Park has proposed changes to its sprawling green space. What happens when environmental and accessibility concerns clash?

Children aged 12 to 17 won’t be vaccinated in Ontario until June at the earliest — that and more in this week’s vaccine update.

The latest coronavirus updates from across the province.

Fewer Ontarians can access and afford dental care because of the pandemic — and that’s renewing calls for universal public funding.